UpdatesPress Release
Viyash Scientific reported strong Q1 results with revenue up 19.5%, EBITDA soaring 59.2%, and PAT more than doubling.
Viyash Scientific LimitedVIYASH · Filed with the exchange
Acquisition of Bio For Life enhances presence in companion animal segment.
No comments yet. Be the first.